AwardedBelgiumGoodsFramework agreement
Spécialités pharmaceutiques à base de vaccins contre le virus de l'hépatite A, contre le virus de l'hépatite B et de vaccins combinés contre le virus de l'hépatite A et contre le virus de l'hépatite B
- Published
- Published 1 September 2025
- Deadline
- Closed 30 September 2025
Overview
Spécialités pharmaceutiques à base de vaccins contre le virus de l'hépatite A, contre le virus de l'hépatite B et de vaccins combinés contre le virus de l'hépatite A et contre le virus de l'hépatite B
Key details
- Country
- Belgium
- Status
- Awarded
- Category
- Goods
- Procedure
- Open
- Contract type
- Framework agreement
- Published
- 1 September 2025
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- €684,617
- Award date
- 21 April 2026
- Contract period
- 22 April 2026 → 21 April 2030
- GlaxoSmithKline
- MSD BELGIUM
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
24 April 2026
Contract Notice
1 September 2025
Contracting authority
Healthcare Public Procurement (HeCaPP)
Procuring entitySaint-Gilles\Sint-Gillis, Belgium
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.